CONTRAVIR PHARMACEUTICALS INC has a total of 27 patent applications. It decreased the IP activity by 16.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ISOTECHNIKA PHARMA INC, TOPOTARGET GERMANY AG and PEPGEN CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Japan | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Taiwan | 2 | |
#8 | Argentina | 1 | |
#9 | China | 1 | |
#10 | Hong Kong | 1 | |
#11 | Hungary | 1 | |
#12 | Israel | 1 | |
#13 | Mexico | 1 | |
#14 | Malaysia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Organic chemistry methods | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Sugiyama Shin | 9 |
#2 | Ure Daren R | 7 |
#3 | Hegmans Alexander | 7 |
#4 | Alexander Hegmans | 6 |
#5 | Mark D Abel | 6 |
#6 | Fenske Bruce W | 6 |
#7 | Trepanier Dan J | 6 |
#8 | Dan J Trepanier | 6 |
#9 | Bruce W Fenske | 6 |
#10 | Abel Mark D | 6 |
Publication | Filing date | Title |
---|---|---|
US2018296588A1 | Combination therapy for treating viral infections | |
WO2018106928A1 | Treatment and prevention of hbv diseases by cyclosporine analogue molecules modified at amino acides 1 and 3 | |
US2017326146A1 | Methods of treating hepatitis b infections and related dosage regimes |